RLAY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Relay Therapeutics Inc

Watchlist Manager

Watchlist

Price: 18.8 USD -1.62% Market Closed

Market Cap: $4.1B

	Relay Therapeutics Inc NASDAQ:RLAY	US
H	Hapag Lloyd AG F:HLAG	DE
A	Automatic Data Processing Inc F:ADP	US
	ESR-REIT OTC:CGIUF	SG
C	CK Power PCL SET:CKP	TH

Profitability Summary

Relay Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2 999%

Negative 3Y Average Operating Margin

-2 589%

Operating Margin is Increasing

-38 933% > -2 999%

Negative Net Margin

-2 764%

Negative 3Y Average Net Margin

-2 362%

Net Margin is Increasing

-36 640% > -2 764%

Negative Free Cash Flow Margin

-2 050%

Negative 3Y Average Free Cash Flow Margin

-1 812%

Free Cash Flow Margin is Increasing

-28 381% > -2 050%

Negative ROE

-37%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-539%

ROIC is Increasing

-597% > -555%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.